The company
Zai Lab Limited - American Depositary Shares
ZLAB · Nasdaq
ZLAB stood above a rising 150-day average in 12 of the last 52 weekly readings, including each of the last 11 weeks. It is 8.2% above that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- Leading
- Weeks in an uptrend
- 11 in a row
- Industry in uptrend
- 15% -17 in 4 wk
- Insider buys, 12 months
- $132K
- Insider sales, 12 months
- $21.8M
- Officials’ trades on record
- 0
- Institutions holding
- 92 (-2)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 12 of 52 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Yajing ChenChief Financial Officer | sold | 260at $27.00 | 19 Aug 2026filed 21 Aug 2026 |
| William LisDirector | sold | 8,506at $25.00 | 12 Aug 2026filed 13 Aug 2026 |
| Yajing ChenChief Financial Officer | sold | 619at $25.00 | 11 Aug 2026filed 13 Aug 2026 |
| Richard GaynorDirector | bought | 1,736at $19.05 | 1 Jul 2026filed 6 Jul 2026 |
| Ying DuChairperson & CEO | sold | 7,026at $18.53 | 30 Jun 2026filed 1 Jul 2026 |
| Yajing ChenChief Financial Officer | sold | 2,264at $17.46 | 26 Jun 2026filed 29 Jun 2026 |
| Ying DuChairperson & CEO | sold | 24,543at $17.46 | 26 Jun 2026filed 29 Jun 2026 |
| Frazor Titus Edmondson IIIChief Legal Officer | sold | 4,103at $17.46 | 26 Jun 2026filed 29 Jun 2026 |
| William LisDirector | sold | 7,040at $18.09 | 22 Jun 2026filed 24 Jun 2026 |
| Ying DuChairperson & CEO | sold | 50,000at $19.00 | 18 May 2026filed 19 May 2026 |
| Ying DuChairperson & CEO | sold | 50,000at $20.74 | 15 May 2026filed 19 May 2026 |
| Ying DuChairperson & CEO | sold | 50,000at $20.09 | 14 May 2026filed 15 May 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| RTW INVESTMENTS, LPunchanged · filed 14 Aug 2026 | 6,574,032$124.9M | 00.0% |
| TCG Crossover Management, LLCnew · filed 14 Aug 2026 | 6,137,627$116.6M | +6,137,627 |
| RA CAPITAL MANAGEMENT, L.P.added · filed 14 Aug 2026 | 5,743,533$109.1M | +36,271+0.6% |
| ADAR1 Capital Management, LLCadded · filed 14 Aug 2026 | 3,369,034$64.0M | +1,943,667+136.4% |
| FMR LLCadded · filed 13 Aug 2026 | 2,815,214$53.5M | +1,552,823+123.0% |
| GOLDMAN SACHS GROUP INCadded · filed 14 Aug 2026 | 2,315,480$44.0M | +2,204,893+1993.8% |
| Woodline Partners LPnew · filed 14 Aug 2026 | 2,207,293$41.9M | +2,207,293 |
| Frazier Life Sciences Management, L.P.unchanged · filed 14 Aug 2026 | 1,902,320$36.1M | 00.0% |
| BAMCO INCreduced · filed 14 Aug 2026 | 1,623,694$30.9M | -34,624−2.1% |
| TWO SIGMA INVESTMENTS, LPadded · filed 14 Aug 2026 | 1,299,394$24.7M | +989,671+319.5% |
News
No headline names it lately.
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.